Jefferies Group LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Sep 21, 2023	BUY	$74.28 - $92.69 $921,072 - $1.15 Million	12,400 Added 44.93%	40,000 $3.08 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $921,072 - $1.15 Million	12,400 Added 44.93%	40,000 $3.08 Million
Q2 2021 Aug 20, 2021	SELL	$75.51 - $84.79 $206 Million - $232 Million	-2,732,400 Reduced 99.0%	27,600 $2.3 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $206 Million - $232 Million	2,732,400 Added 9900.0%	2,760,000 $2.3 Million
Q1 2021 Sep 21, 2023	SELL	$74.73 - $90.69 $1.3 Million - $1.58 Million	-17,400 Reduced 38.67%	27,600 $2.08 Million
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $1.3 Million - $1.58 Million	-17,400 Reduced 38.67%	27,600 $2.08 Million
Q4 2020 Sep 21, 2023	BUY	$72.61 - $90.2 $3.27 Million - $4.06 Million	45,000 New	45,000 $3.95 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $2.56 Million - $3.18 Million	35,300 Added 363.92%	45,000 $3.95 Million
Q3 2020 Nov 13, 2020	SELL	$71.87 - $131.03 $380,911 - $694,459	-5,300 Reduced 35.33%	9,700 $738,000
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $6.1 Million - $8.28 Million	-85,500 Reduced 85.07%	15,000 $1.27 Million
Q4 2019 Feb 13, 2020	BUY	$64.27 - $86.37 $2.01 Million - $2.7 Million	31,300 Added 45.23%	100,500 $8.5 Million
Q3 2019 Nov 13, 2019	BUY	$67.4 - $85.11 $2.35 Million - $2.97 Million	34,900 Added 101.75%	69,200 $4.66 Million
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $7.17 Million - $8.39 Million	-85,100 Reduced 71.27%	34,300 $3.05 Million
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $8.45 Million - $11.2 Million	105,400 Added 752.86%	119,400 $10.2 Million
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $957,984 - $1.08 Million	10,200 Added 268.42%	14,000 $1.36 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $98,813 - $128,739	1,300 Added 52.0%	3,800 $358,000
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $194,175 - $231,575	2,500 New	2,500 $203,000

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.44 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.22 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.2 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$881 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$666 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account